设为首页 加入收藏

TOP

Kadcyla(十八)
2013-09-23 16:14:39 来源: 作者: 【 】 浏览:10640次 评论:0
ember of the Roche Group Kadcyla is a trademark of Genentech, Inc.
1 DNA Way ©2013 Genentech, Inc.
South San Francisco, CA 94080-4990 
U.S. License No: 1048 

Representative sample of labeling (see the HOW SUPPLIED section for complete listing):

PRINCIPAL DISPLAY PANEL - 100 mg Vial Label

NDC 50242-088-01

Kadcyla™
(ado-trastuzumab
emtansine)
For Injection

100 mg per vial

For Intravenous Infusion Only
Reconstitute and Dilute prior
to administration
Single-Dose Vial –
Discard Unused Portion

KEEP REFRIGERATED

Rx only

1 vial

Genentech

10135258


PRINCIPAL DISPLAY PANEL - 160 mg Vial Label

NDC 50242-087-01

Kadcyla™
(ado-trastuzumab
emtansine)
For Injection

160 mg per vial

For Intravenous Infusion Only
Reconstitute and Dilute prior
to administration
Single-Dose Vial –
Discard Unused Portion

KEEP REFRIGERATED

Rx only

1 vial

Genentech

4862100


Kadcyla
ado-trastuzumab emtansine injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:50242-088
Route of Administration INTRAVENOUS DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ADO-TRASTUZUMAB EMTANSINE (ADO-TRASTUZUMAB EMTANSINE) ADO-TRASTUZUMAB EMTANSINE 20 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
SUCROSE 60 mg  in 1 mL
SUCCINIC ACID 1.18 mg  in 1 mL
SODIUM HYDROXIDE 0.45 mg  in 1 mL
POLYSORBATE 20 0.2 mg  in 1 mL
WATER  
Packaging
Item Code Package Description
1 NDC:50242-088-01 1 VIAL, SINGLE-USE in 1 CARTON
1  5 mL in 1 VIAL, SINGLE-USE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125427 02/22/2013 
Kadcyla
ado-trastuzumab emtansine injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:50242-087
Route of Administration INTRAVENOUS DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ADO-TRASTUZUMAB EMTANSINE (ADO-TRASTUZUMAB EMTANSINE) ADO-TRASTUZUMAB EMTANSINE 20 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
SUCROSE 60 mg  in 1 mL
SUCCINIC ACID 1.18 mg  in 1 mL
SODIUM HYDROXIDE 0.45 mg  in 1 mL
POLYSORBATE 20 0.2 mg  in 1 mL
WATER  
Packaging
Item Code Package Description
1 NDC:50242-087-01 1 VIAL, SINGLE-USE in 1 CARTON
1  8 mL in 1 VIAL, SINGLE-USE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125427 02/22/2013 
Labeler - Genentech, Inc. (080129000)
Establishment
Name Address ID/FEI Operations
Genentech, Inc. (Hillsboro)  833220176 LABEL(50242-088, 50242-087), PACK(50242-088, 50242-087)

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 15 16 17 18 下一页 尾页 18/18/18
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇ONTAK(denileukin diftitox)injec.. 下一篇KADCYLA (trastuzumab emtansine)..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位